发明名称 CONJUGATE POSSESSING SELECTIVE EFFECT WITH RESPECT TO CANCER TUMORS
摘要 FIELD: medicine, oncology, pharmacology. ^ SUBSTANCE: invention involves creature of conjugate showing a broad spectrum of effect and showing selectivity and specificity of anti-angiogenic agents in combination with high effectiveness of cytotoxic preparations. Invention is based on using polypeptide-containing conjugate added covalently to cytotoxic chemical preparation molecule through an acid-labile bond using a cross-linking agent. Endostatin or angiostatin or their biologically active truncated fragments are used as polypeptide, and cytotoxic chemical preparation comprises at least one reactive amino-group. A cross-linking agent is chosen from group of dialdehydes and wherein the ratio of polypeptide to cytotoxic preparation = 1:(1-3). Invention provides the high anticancer activity against cancer cells of different strains and against endothelial cells also. Invention can be used as an anticancer medicinal agent of the direct effect. ^ EFFECT: valuable medicinal properties of conjugate. ^ 2 cl, 3 tbl, 4 ex
申请公布号 RU2303997(C2) 申请公布日期 2007.08.10
申请号 RU20050129620 申请日期 2005.09.27
申请人 AVTONOMNAJA NEKOMMERCHESKAJA ORGANIZATSIJA NAUCHNO-TEKHNICHESKIJ TSENTR "FARMBIOPRESS" 发明人 LUTSENKO ELENA VALER'EVNA;LUTSENKO SERGEJ VIKTOROVICH;DIGTJAR' ANTON VASIL'EVICH;KISELEV SERGEJ MIKHAJLOVICH;FEL'DMAN NATAL'JA BORISOVNA
分类号 A61K38/17;A61K31/429;A61P35/00 主分类号 A61K38/17
代理机构 代理人
主权项
地址